Grail (NASDAQ:GRAL) Sets New 12-Month High – Time to Buy?

Grail, Inc. (NASDAQ:GRAL)’s stock price reached a new 52-week high during trading on Friday . The stock traded as high as $31.59 and last traded at $31.51, with a volume of 1479432 shares traded. The stock had previously closed at $26.67.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on GRAL. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target for the company. Wolfe Research assumed coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating for the company. Finally, Guggenheim assumed coverage on shares of Grail in a research note on Thursday, October 17th. They issued a “neutral” rating for the company.

Grail Stock Up 18.1 %

The stock has a 50 day moving average of $19.76 and a 200 day moving average of $16.48.

Grail (NASDAQ:GRAL) last issued its earnings results on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The firm had revenue of $28.65 million during the quarter. Analysts anticipate that Grail, Inc. will post -65.16 EPS for the current fiscal year.

Insider Buying and Selling at Grail

In other news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the transaction, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Hedge Funds Weigh In On Grail

A number of large investors have recently bought and sold shares of the business. FNY Investment Advisers LLC acquired a new stake in Grail in the fourth quarter worth $26,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Grail in the 4th quarter worth about $64,000. Manchester Capital Management LLC bought a new stake in Grail in the 4th quarter valued at about $123,000. China Universal Asset Management Co. Ltd. acquired a new position in Grail during the 4th quarter valued at about $127,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Grail in the 4th quarter worth about $244,000.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.